Home › Funds › Arrowstreet Capital › HCA

Arrowstreet Capital position in HCA

HCA HEALTHCARE INC · Health Care

Arrowstreet Capital reported holding 1,996,018 shares of HCA (HCA HEALTHCARE INC) in its Q3 2026 13F filing — a position valued at US$851.8M, representing 0.36% of its reported portfolio and ranking #50 among its reported holdings. Arrowstreet Capital has disclosed HCA holdings in 40 of the last 44 reported quarters, going back to Q4 2015.

Latest position (Q3 2026)2.00M sh
Reported value held$851.78M
Portfolio Weight0.36%
First reportedQ4 2015
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Arrowstreet Capital's HCA position evolved

Arrowstreet Capital first disclosed a stake in HCA in Q4 2015 at 95,875 shares (US$2.0M). The position peaked in Q4 2025 at 2,311,112 shares, worth US$1.08B. Across 40 filings, Arrowstreet Capital increased the stake 18 time(s), trimmed it 20 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,996,018 shares valued at US$851.8M — a reduction of -213,467 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2019 (shares rose 23% over the following quarter), a 36% trim in Q4 2019 (shares fell 39% over the following quarter), a 105% increase in Q2 2023 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2015 95.88K $1.96M New
Q1 2017 2.31M $205.35M New
Q2 2017 2.89M $251.81M Add
Q3 2017 3.32M $264.27M Add
Q4 2017 2.98M $261.85M Reduce
Q1 2018 2.77M $268.37M Reduce
Q2 2018 3.52M $361.37M Add
Q3 2018 4.36M $606.17M Add
Q4 2018 4.07M $506.57M Reduce
Q1 2019 4.04M $526.65M Reduce
Q2 2019 3.45M $466.51M Reduce
Q3 2019 2.05M $247.21M Reduce
Q4 2019 1.32M $194.55M Reduce
Q1 2020 1.15M $103.26M Reduce
Q2 2020 1.35M $130.93M Add
Q3 2020 1.73M $215.49M Add
Q4 2020 1.64M $269.81M Reduce
Q1 2021 1.78M $335.93M Add
Q2 2021 2.25M $465.64M Add
Q3 2021 2.29M $556.37M Add
Q4 2021 2.45M $630.40M Add
Q1 2022 2.80M $701.95M Add
Q2 2022 2.82M $474.33M Add
Q3 2022 2.02M $371.84M Reduce
Q4 2022 1.60M $384.49M Reduce
Q1 2023 1.46M $385.65M Reduce
Q2 2023 2.99M $908.61M Add
Q3 2023 3.25M $799.30M Add
Q4 2023 2.70M $730.57M Reduce
Q1 2024 2.58M $859.54M Reduce
Q2 2024 2.52M $809.99M Reduce
Q3 2024 2.55M $1.04B Add
Q4 2024 2.52M $756.33M Reduce
Q1 2025 2.10M $726.88M Reduce
Q2 2025 2.03M $777.24M Reduce
Q3 2025 2.07M $880.20M Add
Q4 2025 2.31M $1.08B Add
Q1 2026 2.17M $1.02B Reduce
Q2 2026 2.21M $861.46M Add
Q3 2026 2.00M $851.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HCA and 13F data

HCA (HCA HEALTHCARE INC) is a Health Care company. 23 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.75B), First Eagle Investment Management (US$1.39B), NORDEA INVESTMENT MANAGEMENT AB (US$602.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HCA

All HCA fund holders →

FAQ

How long has Arrowstreet Capital held HCA?

Arrowstreet Capital has disclosed HCA holdings in 40 of the last 44 reported quarters, going back to Q4 2015.

What is Arrowstreet Capital's current position in HCA?

As of Q3 2026, Arrowstreet Capital holds 2.00M shares of HCA (HCA HEALTHCARE INC), valued at $851.78M, representing 0.36% of its reported portfolio and ranking #50.

Has Arrowstreet Capital been buying or selling HCA?

In the latest 13F filing (Q3 2026), Arrowstreet Capital reduced its position in HCA. The position peaked in Q4 2025 at 2.31M shares.

Which other funds hold HCA?

Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, NORDEA INVESTMENT MANAGEMENT AB, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.